Loading company…
Oncolys BioPharma is a Tokyo-based biopharmaceutical company researching therapies for oncology and infectious diseases.
Founded in 2004 and headquartered in Tokyo, Japan, Oncolys BioPharma Inc. researches and develops therapeutics for oncology and infectious diseases. The company completed an IPO in December 2013, raising JPY 6600 million by issuing 2.55 million shares at JPY 2600 each, and has taken part in five deals since inception. Reported 2023 revenue was JPY 449,646.4 and EBITDA was -JPY 13,745,686.6. It is at the Series C stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in